
Prompt:
Identify the key legal concepts and principles related to the provided laws.
I will provide a context, which will follow the label "Context:"


Context: {'id': '164.502(a)(5)(ii)(B)(2)(ii)', 'data': '(ii) For research purposes pursuant to § 164.512(i) or § 164.514(e), where the only remuneration received by the covered entity or business associate is a reasonable cost-based fee to cover the cost to prepare and transmit the protected health information for such purposes; '}, {'id': '164.512', 'data': '§ 164.512 Uses and disclosures for which an authorization or opportunity to agree or object is not required. A covered entity may use or disclose protected health information without the written authorization of the individual, as described in § 164.508, or the opportunity for the individual to agree or object as described in § 164.510, in the situations covered by this section, subject to the applicable requirements of this section. When the covered entity is required by this section to inform the individual of, or when the individual may agree to, a use or disclosure permitted by this section, the covered entity's information and the individual's agreement may be given orally. '}, {'id': '164.512(i)(1)', 'data': '(1) Permitted uses and disclosures.  A covered entity may use or disclose protected health information for research, regardless of the source of funding of the research, provided that: '}, {'id': '164.512(i)(2)', 'data': '(2) Documentation of waiver approval.  For a use or disclosure to be permitted based on documentation of approval of an alteration or waiver, under paragraph (i)(1)(i) of this section, the documentation must include all of the following: '}, {'id': '164.514(d)(3)(iii)(D)', 'data': '(D) Documentation or representations that comply with the applicable requirements of § 164.512(i) have been provided by a person requesting the information for research purposes. '}, {'id': '164.528(b)(4)(i)', 'data': '(i) If, during the period covered by the accounting, the covered entity has made disclosures of protected health information for a particular research purpose in accordance with § 164.512(i) for 50 or more individuals, the accounting may, with respect to such disclosures for which the protected health information about the individual may have been included, provide: '}, {'id': '164.532(a)', 'data': '(a) Standard: Effect of prior authorizations.  Notwithstanding §§ 164.508 and 164.512(i), a covered entity may use or disclose protected health information, consistent with paragraphs (b) and (c) of this section, pursuant to an authorization or other express legal permission obtained from an individual permitting the use or disclosure of protected health information, informed consent of the individual to participate in research, a waiver of informed consent by an IRB, or a waiver of authorization in accordance with § 164.512(i)(1)(i). '}, {'id': '164.532(c)', 'data': '(c) Implementation specification: Effect of prior permission for research.  Notwithstanding any provisions in §§ 164.508 and 164.512(i), a covered entity may, to the extent allowed by one of the following permissions, use or disclose, for research, protected health information that it created or received either before or after the applicable compliance date of this subpart, provided that there is no agreed-to restriction in accordance with § 164.522(a), and the covered entity has obtained, prior to the applicable compliance date, either: '}, {'id': '164.512', 'data': '§ 164.512 Uses and disclosures for which an authorization or opportunity to agree or object is not required. A covered entity may use or disclose protected health information without the written authorization of the individual, as described in § 164.508, or the opportunity for the individual to agree or object as described in § 164.510, in the situations covered by this section, subject to the applicable requirements of this section. When the covered entity is required by this section to inform the individual of, or when the individual may agree to, a use or disclosure permitted by this section, the covered entity's information and the individual's agreement may be given orally. '}, {'id': '164.512(i)(1)', 'data': '(1) Permitted uses and disclosures.  A covered entity may use or disclose protected health information for research, regardless of the source of funding of the research, provided that: '}, {'id': '164.512(i)(2)', 'data': '(2) Documentation of waiver approval.  For a use or disclosure to be permitted based on documentation of approval of an alteration or waiver, under paragraph (i)(1)(i) of this section, the documentation must include all of the following: '}, {'id': '164.502(a)(5)(ii)(B)(2)(ii)', 'data': '(ii) For research purposes pursuant to § 164.512(i) or § 164.514(e), where the only remuneration received by the covered entity or business associate is a reasonable cost-based fee to cover the cost to prepare and transmit the protected health information for such purposes; '}, {'id': '164.514(d)(3)(iii)(D)', 'data': '(D) Documentation or representations that comply with the applicable requirements of § 164.512(i) have been provided by a person requesting the information for research purposes. '}, {'id': '164.528(b)(4)(i)', 'data': '(i) If, during the period covered by the accounting, the covered entity has made disclosures of protected health information for a particular research purpose in accordance with § 164.512(i) for 50 or more individuals, the accounting may, with respect to such disclosures for which the protected health information about the individual may have been included, provide: '}, {'id': '164.532(a)', 'data': '(a) Standard: Effect of prior authorizations.  Notwithstanding §§ 164.508 and 164.512(i), a covered entity may use or disclose protected health information, consistent with paragraphs (b) and (c) of this section, pursuant to an authorization or other express legal permission obtained from an individual permitting the use or disclosure of protected health information, informed consent of the individual to participate in research, a waiver of informed consent by an IRB, or a waiver of authorization in accordance with § 164.512(i)(1)(i). '}, {'id': '164.532(c)', 'data': '(c) Implementation specification: Effect of prior permission for research.  Notwithstanding any provisions in §§ 164.508 and 164.512(i), a covered entity may, to the extent allowed by one of the following permissions, use or disclose, for research, protected health information that it created or received either before or after the applicable compliance date of this subpart, provided that there is no agreed-to restriction in accordance with § 164.522(a), and the covered entity has obtained, prior to the applicable compliance date, either: '}


Output Struct:
{ 
	"key legal concepts": ["explanation of concept 1", "explanation of concept 2", ...], 
	"key legal principles": ["explanation of principle 1", "explanation of principle 2", ...],
	"application scenarios": ["something", "something"],
	"relationship to overall document argument": ["something", "something"]
}


You should focus solely on explaining THIS LAW within the given context:
THIS LAW:
{'id': '164.512(i)', 'data': '(i) Standard: Uses and disclosures for research purposes —'}
You may now respond.
